Comments: NJ A4052 | 2022-2023 | Regular Session

Bill Title: Establishes three-year sickle cell disease pilot program; appropriates $10,200,000.

Spectrum: Strong Partisan Bill (Democrat 24-2)

Status: (Passed) 2024-01-08 - Approved P.L.2023, c.242. [A4052 Detail]

Text: Latest bill text (Amended) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey A4052 at this time.

Social Comments on NJ A4052

feedback